准UFL1-PARP1轴可以增强抗瘤免疫力
Wenjing Song1, Chuan He2, Xixin Xing2
1Department of Hepatobiliary and Pancreatic Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province, Wuhan 430071, China; Department of Breast Center, The Second Hospital of Shandong University, Jinan 250033, China.
Cell reports
|October 17, 2025
概括
通过稳定PARP1.1,UFMylation促进胰腺癌的生长和免疫疗法耐药性. 抑制UFMylation通过促进胰腺管道腺癌中的CD8+T细胞透来提高抗PD-1疗法的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 胰腺管道腺癌 (PDAC) 对癌症免疫疗法的反应不佳.
- 在PDAC中UFMylation的作用,一个翻译后修改,以及其对免疫治疗的影响仍然基本上是未知的.
研究的目的:
- 调查UFMylation在PDAC进展和免疫治疗耐药性的作用.
- 阐明UFMylation影响PDAC免疫逃避的分子机制.
- 评估UFMylation作为增强PDAC免疫疗法的潜在治疗标.
主要方法:
- 在临床前模型中研究了UFMylation对PDAC生长和免疫逃避的影响.
- 使用生物化学测试来确定UFL1,PARP1和无处不在途径之间的相互作用.
- 评估了UFMylation抑制对DNA损伤修复,R循环形成和cGAS-STING通路激活的影响.
- 在PDAC模型中评估了与UFMylation抑制结合的抗PD-1免疫疗法的疗效.
- 在临床PDAC样本中的相关UFL1,PARP1,cGAS-STING和CD8+T细胞水平.
主要成果:
- 发现UFMylation驱动PDAC生长,并赋予免疫治疗的耐药性.
- E3结合酶UFL1通过防止其无处不在和降解来稳定PARP1.
- 稳定的PARP1增强了DNA修复,抑制了R循环的形成,并抑制了cGAS-STING的激活,从而导致免疫逃避.
- 抑制UFMylation可以逆转这些影响,促进CD8+T细胞的透,提高抗PD-1疗法的疗效.
- 临床数据显示UFL1和PARP1之间的正相关性,以及与cGAS-STING激活和PDAC中的CD8+T细胞透的反相关性.
结论:
- 在促进PDAC生长和免疫逃避方面,UFMylation起着至关重要的作用.
- 通过抑制UFL1,准UFMylation是克服PDAC免疫疗法耐药性的有希望的策略.
- 联合UFMylation抑制和抗PD-1治疗可能会改善PDAC患者的临床结果.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K